LEO Pharma To Purchase Peplin For $287.5M
Danish pharmaceutical company LEO Pharma A/S has announced plans to acquire Peplin Inc. for $287.5 million, a move intended to bolster LEO's line of dermatology products....To view the full article, register now.
Already a subscriber? Click here to view full article